Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
A major, though still unnamed, China biopharma bought a...
Regeneron Pharmaceuticals and Bayer...
Bayer HealthCare and Peking University...
Bayer AG will acquire Dihon...
Bayer HealthCare will invest $138...
Bayer AG closed its $589 million...
Bayer AG announced that the CFDA has...
Bayer AG completed construction of the...
Hope Medicine, a China startup, acquired a global license...
CStone Pharma of Suzhou will test its PD-L1 monoclonal...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China